EQS-News: Alzchem Group AG: Private placement of Alzchem shares by LIVIA Corporate Development SE and HDI Vier CE GmbH successfully completed
|
EQS-News: Alzchem Group AG
/ Key word(s): Miscellaneous
Alzchem Group AG: Private placement of Alzchem shares by LIVIA Corporate Development SE and HDI Vier CE GmbH successfully completed Trostberg, December 11, 2024 – Alzchem Group AG has been informed by its shareholders, LIVIA Corporate Development SE und HDI Vier CE GmbH, that the announced private placement of 250,000 shares (representing approximately 2.5% of the share capital) through an accelerated bookbuilding process with institutional investors has been successfully completed.
About Alzchem Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments. The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.
11.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Alzchem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 2048485 |
| End of News | EQS News Service |
|
|
2048485 11.12.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | ||
| Sales1 | 376,07 | 379,26 | 422,29 | 542,22 | 540,65 | 570,00 | 0,00 | |
| EBITDA1,2 | 50,08 | 53,81 | 62,05 | 61,44 | 81,37 | 103,00 | 0,00 | |
| EBITDA-Margin3 | 13,32 | 14,19 | 14,69 | 11,33 | 15,05 | 18,07 | 0,00 | |
| EBIT1,4 | 30,59 | 30,71 | 37,57 | 35,90 | 55,47 | 78,40 | 0,00 | |
| EBIT-Margin5 | 8,13 | 8,10 | 8,90 | 6,62 | 10,26 | 13,75 | 0,00 | |
| Net Profit (Loss)1 | 18,15 | 19,87 | 27,76 | 30,22 | 34,79 | 48,50 | 0,00 | |
| Net-Margin6 | 4,83 | 5,24 | 6,57 | 5,57 | 6,44 | 8,51 | 0,00 | |
| Cashflow1,7 | 43,63 | 48,71 | 43,02 | -4,24 | 72,67 | 59,00 | 0,00 | |
| Earnings per share8 | 1,77 | 1,94 | 2,72 | 2,96 | 3,40 | 4,75 | 4,30 | |
| Dividend per share8 | 0,75 | 0,77 | 1,00 | 1,05 | 1,20 | 1,20 | 1,25 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: RSM Ebner Stolz
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Alzchem Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2YNT3 | DE000A2YNT30 | AG | 580,05 Mio € | Kaufen | 8FWJ2HC2+23 | |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 13,26 | 13,77 | 0,95 | 23,96 | 3,88 | 7,98 | 1,06 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 1,05 | 1,20 | 1,20 | 2,11% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 08.05.2025 | 30.04.2025 | 30.07.2025 | 07.11.2024 | 28.02.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,44% | +16,68% | +119,23% | +119,23% | +1.914,13% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
